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Abstract
Background/Aim: Tumor-secreted extracellular vesicles (EVs) play an important role as mediators of
intercellular communication and hypoxia is a common feature of solid tumors frequently associated with
an aggressive clinical behavior. This study aimed to gain a deeper understanding into the functions of
EVs in intercellular communication between primary and metastatic cancer cells under hypoxic
conditions. Materials and Methods: EVs were isolated from two isogenic colorectal cancer (CRC) cell
lines SW480 and SW620 cultured under normoxic and hypoxic conditions. Their uptake and effects in
SW480 and SW620 cells were studied using EV uptake, proliferation, spheroid-formation, wound healing
and invasion assays. Results: Our data showed that hypoxia enhanced the release of EVs from CRC cells
in a Hypoxia Induced Factor 1-dependent manner. Hypoxic EVs were taken up by CRC cells more
efficiently than normoxic EVs. Hypoxic EVs stimulated motility, invasiveness and stemness of primary
tumour-derived SW480 cells, whereas they had a little effect on metastasis-derived SW620 cells.
Conclusion: This study supports the hypothesis that hypoxic colorectal cancer-derived EVs confer
aggressiveness and invasiveness to hypoxia-naïve cancer cells.
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Hypoxia is a common property of the majority of solid cancers, including colorectal cancer (CRC).
Accumulating evidence shows that up to 50-60% of locally advanced solid tumors have hypoxic tissue
areas (pO2 £2.5 mmHg) (1). Hypoxic areas temporally arise in the tumor tissues due to rapid proliferation
of cancer cells and abnormal vasculature (2). Majority of cells exposed to acute hypoxia halt their
proliferation and/or undergo apoptotic or necrotic cell death (1). However, under sustained hypoxia a
fraction of cancer cells survive and acquire capabilities that enable them to overcome nutrient and oxygen
deprivation and/or escape from the hostile environment (1). Clinically, hypoxia is associated with
metastasis, drug resistance and poor prognosis (3-5). Intracellular hypoxia signaling is mediated by
hypoxia-inducible factors (HIFs) - transcription factors that exist as heterodimers formed of an a-subunit
(HIF-1a, HIF-2a or HIF3a) and b-subunit (HIF-1b). The stability of HIFa protein is controlled by
oxygen level, while HIF-1b is constitutively expressed. Under normoxic conditions, HIFa interacts with
VHL protein, which activates the ubiquitin ligase system leading to the degradation of HIFa by the 26S
proteasome, while under hypoxic conditions, it is stabilized and forms dimers with HIF-1b (2, 4, 6). Upon
dimerization, HIF is translocated to the nucleus, where it controls the expression of genes involved in
invasion, metastasis, angiogenesis, stemness, dormancy and metabolic reprogramming (2, 5). However,
given that the hypoxic areas are typically located in the central parts of the tumors, it is not clear if the
cells exposed to hypoxia can exit the tumor and subsequently spread to secondary sites by themselves or
whether they contribute to the metastatic progression mainly via signaling to the cells located at the
invasive front.
Extracellular vesicles (EVs) have recently emerged as important mediators of the communication between
cells. EVs are a heterogeneous population of lipid bilayer-bound vesicles released into the extracellular
space by normal and cancer cells. Three main types of EVs are exosomes, microvesicles and apoptotic
bodies that differ in their biogenesis, and probably also in their molecular content, membrane composition
and specific functions (7, 8). The molecular content of EVs at least partially reflects that of the parent
cells. EVs transfer a variety of lipids, proteins, mRNAs, non-coding and structural RNAs and even DNA
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fragments to recipient cells, thereby influencing their physiological functions (7, 9). EVs produced by
normal cells are required for the maintenance of homeostasis and the regulation of various physiological
functions (7), whereas cancer-derived EVs have been shown to promote tumor growth and metastasis by
influencing properties of cancer cells, immune cells, and the stromal cells in the tumor microenvironment
and at the pre-metastatic niches (10-12). CRC-derived EVs have been shown to stimulate proliferation,
motility, colony-forming efficiency and chemoresistance of cancer cells (13-15) and to elicit various
tumor-promoting effects in endothelial cells (16), mesenchymal stromal cells (17) and immune cells (18).
The current study investigated the effects of EVs released by two isogenic CRC cell lines SW480 and
SW620, which were cultured under normoxic and hypoxic conditions on hypoxia-naïve CRC cells. These
cell lines were originally established from the primary tumor and the lymph node metastasis obtained
from the same patient and therefore represent an in vitro model for studying the molecular mechanisms of
CRC metastasis (19). Results showed that hypoxic EVs were more efficiently taken up by hypoxia- naïve
SW480 and SW620 cells than normoxic EVs, and hypoxic EVs promoted motility, invasion and
spheroid-forming capacity of primary tumor-derived SW480 cells.
Materials and Methods
Cell culture and exposure to hypoxia. The human colorectal adenocarcinoma cell lines SW480 and
SW620 were purchased from the American Type Culture Collection (ATCC, USA). The cells were
maintained in DMEM/F12 medium (Lonza, Basel, Switzerland, #BE12-79F) supplemented with 10%
Foetal Bovine Serum (Sigma-Aldrich, St. Louis, MO, USA, #F7524) and 1´ Antibiotic-Antimycotic
(Thermo Fisher Scientific, Waltham, MA, USA, #15240-062) as adherent monolayer. The cell cultures
were monitored for mycoplasma infection using PCR Mycoplasma Test Kit I/C (PromoCell GmbH,
Heidelberg, Germany, #PK-CA91-1096). For EV isolation, the cells were seeded at a density 1´106 cells
per ml of serum-free DMEM/F12 medium supplemented with 10 ng/ml bFGF (Santa Cruz
Biotechnology, Dallas, TX, USA, #sc-4573), 20 ng/ml EGF (R&D Systems, Minneapolis, MN, USA,
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#236-EG-200), 0.5 µg/ml hydrocortisone (Sigma-Aldrich, #H0135), 1´ Antibiotic-Antimycotic (Thermo
Fisher Scientific, #15240-062)  and 1´B-27 (Thermo Fisher Scientific, #17504001), and grown as
multicellular spheroids for 48 h. To establish hypoxic conditions, the cells were cultured at 1% O2, 94%
N2 and 5% CO2 in a humidified multi-gas incubator (SANYO Electric Co., Osaka, Japan, #MCO-5M). To
test the effects of HIF-1 inhibition on the EV release, cells were treated with 300 µM chetomin (Sigma-
Aldrich, #C9623) for 48 h.
Immunofluorescence. After 48 h exposure to hypoxia, multicellular spheroids were washed with PBS,
centrifuged onto poly–L-lysine-coated slides (Tharmac GmbH, Waldsolms, Germany, #JC312) using a
Shandon cytospin at 1000 g for 5 min and fixed in cold methanol/acetone (1:1) for 20 min. The slides
were blocked with 2% BSA in PBS for 30 min and incubated with primary antibodies – rabbit anti- CAIX
(Abcam, Cambridge, UK, #ab15086) (dilution 1:50) or mouse monoclonal anti-HIF1α (R&D Systems,
#MAB1935) (dilution 1:50) overnight at + 4◦C. After washing, the slides were incubated with secondary
antibodies – goat anti-rabbit IgG conjugated with fluorescein (FITC) (Jackson ImmunoResearch,
Cambridgeshire, UK, #11-095-006) or goat anti-mouse IgG conjugated with cyanine (Cy3) (Jackson
ImmunoResearch, #115-165-0) (dilution 1:200) for 1 h at room temperature. The slides were mounted
with ProLong Gold Antifade Mountant with DAPI (Thermo Fisher Scientific, #P36935) and images were
acquired using Leica DM3000 microscope (Leica Microsystems GmbH, Wetzlar, Germany).
EV isolation. EVs were isolated from the conditioned cell culture media using size exclusion
chromatography (SEC) as described before (20). Briefly, culture media were centrifuged at 300 g for 10
min to remove cells and at 3000 g for 30 min at +4°C to remove cell debris, then filtered through 0.2 mm
filters (Sarstedt, #83.1826.001) and concentrated up to 1 ml using 100 kDa centrifugal filters (Merck
Millipore, UFC910024). The media were loaded on CL6B sepharose-filled 10 ml SEC columns and 12
sequential 0.5 ml fractions were collected. Each SEC fraction was measured by Zetasizer Nano ZS
(Malvern, UK) and the fractions containing particles from 30 to 200 nm were pooled, concentrated up to
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100 ml using 3kDa filters (Merck, Millipore, UFC500324), aliquoted to avoid repeated freeze/thaw cycles
and stored at -20ºC. EV protein concentration was measured by Pierce BCA Protein Assay Kit (Thermo
Fisher Scientific, #23227).
Western blot. Cells and EVs were lysed in RIPA buffer (50 mM Tris, pH 8.0, 0.6 M NaCl, 4% Triton X-
100, 2% sodium deoxycholate, 0.1% SDS) and the protein concentration was determined using a BCA
Protein Assay kit (Pierce, Thermo Fisher Scientific). Ten micrograms of total protein were loaded per
lane, separated by 10% SDS-PAGE and electroblotted to nitrocellulose membranes. The membranes were
blocked with 10% (w/v) fat-free milk and then incubated with the following primary antibodies: HIF1α
(1:2000) (Abcam, #ab51608), CAIX (1:1000) (Abcam, #ab15086), ALIX (1:1000) (Santa Cruz, #sc-
53540), TSG101 (1:1000) (Abcam, #ab125011), CD9 (1:500) (Santa Cruz, sc-13118), Calnexin (1:1000)
(Abcam, #ab22595) and b-actin (1:4000) (Abcam, #ab8224). The membranes were washed in TBS,
0.05% Tween and incubated with peroxidase - conjugated rabbit anti-mouse secondary antibody (1:2000)
(Santa Cruz, #sc-516102) or mouse anti-rabbit secondary antibody (1:2000) (Santa Cruz, #sc-2357) and
processed with ECL Select Western Blotting Detection Reagents (GE Healthcare, USA) according to
manufacturer’s instructions.
Nanoparticle tracking analysis. Isolated EVs were evaluated by nanoparticle tracking analysis (NTA)
using Nanosight instrument LM14 (Malvern, UK) equipped with violet (404 nm, 70 mW) laser and
SCMOS camera. The samples were diluted in filtered PBS to achieve particle concentration in range from
1´108 to 1´109 particles/ml and three 60 sec videos were recorded using camera level 14. The data were
analyzed using NTA software v3.0 with the detection threshold 10 and screen gain at 5.
Labelling of EVs and EV uptake assay. Isolated EVs (10 mg protein that corresponds to 1.7´109±3.2´108
particles according to NTA data) were stained with 0.5 µl PKH67 dye (Sigma- Aldrich, #MINI67) in 250
µl Diluent C buffer for 5 min at room temperature. The staining reaction was stopped by adding 500 µl of
1% BSA in PBS. Labelled EVs were washed six times with 500ml PBS by centrifuging at 14,000 g for 6
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min using 300 kDa centrifugal filter units (Pall Corporation, #OD300C33). As a negative control for the
uptake experiments, the PKH67 dye without EVs was processed and used in parallel.
SW480 and SW620 cells were seeded in DMEM/F12 complete medium at a density of 1´105 cells per
well in 12 well plates and grown as a monolayer for 24 h at hypoxic or normoxic conditions. PKH67-
labelled EVs (10 mg protein) were added to the cells and incubated for 24 h at 37ºC. Subsequently, cells
were washed with PBS, harvested using 1 ´ trypsin (Thermo Fisher Scientific, #15090-046) and analyzed
with the BD FACSAria II instrument (BD Biosciences, BD FACSAria II). The negative control and auto
fluorescence percentage was subtracted from the results. The assay was performed in duplicate at two
independent times.
For confocal microscopy analysis, 2´105 SW480 cells were seeded on glass coverslips. After 24 h, the
growth medium was changed and PKH67-labelled SW480-derived EVs (10 mg protein) were added to the
cell culture and incubated for another 24 h. Subsequently, cells were washed three times with the growth
media, fixed with 4% buffered FA solution for 10 min and mounted on glass slides in ProLong™ Gold
Antifade Mountant with DAPI (Thermo Fisher Scientific, P36935). Confocal fluorescence imaging was
done on Leica TCS SP8 confocal laser scanning microscopy platform.
Proliferation assay. SW480 and SW620 cells were seeded at a density of 5´103 cells per well in
DMEM/F12 medium in 96 well plate. After 24 h of incubation, 10 µg of normoxic and hypoxic SW480
and SW620-derived EVs were added to the cells and incubated for 24 h at 37°C, 5% CO2. Next, 10 µl of
the CCK8 solution (Sigma-Aldrich, #96992) were added to each well and incubated for 4 h at 37°C, 5%
CO2. The absorbance was measured at 450 nm using a microplate reader (Perkin Elmer, Victor) and the
values were background subtracted. The assay was performed in triplicates at two independent times.
Scratch wound healing assay. SW480 and SW620 cells were seeded in DMEM/F12 complete medium at
a density of 2´105 cells per well in 24 well plates and grown until they reached ~70-80% confluence.
Scratches were created by scraping the monolayer with a sterile 200 ml pipette tip, the wells were washed
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with PBS to remove detached cells and refiled with fresh medium. EVs (20 mg protein) were added to the
cells and photos of the wounds were taken at 0 h and 24 h. Migration distance was measured using
ImageJ software (Leica, Fiji). The assay was performed in triplicates at two independent times.
Cell invasion assay. SW480 and SW620 cell invasion through basement membrane extract (BME) was
tested using Cultrex BME Cell Invasion Assay (R&D Systems, #3455-096-K) according to the
manufacturer’s protocol. Briefly, a filter insert (pore size of 8 mm) was coated with 50 ml of 0.5´BME
overnight at 37ºC in CO2 incubator. On the next day, 5´104 cells in 50 ml of serum-free medium
containing EVs (10 mg protein) were added to the upper chambers, the bottom chambers were filled with
150 µl of medium containing 10% FBS, and incubated for 48 h at 37ºC. The cells that migrated through
the BME layer were dissociated from the membrane, incubated with Calcein AM for 1 h and the
absorbance was measured at 450 nm using a microplate reader (Perkin Elmer, Victor). The assay was
performed in six replicates at two independent times.
Spheroid formation assay. SW480 and SW620 cells were seeded in DMEM/F12 complete medium at a
density of 1´105 cells per well in 6 well plates, grown for 24 h and then incubated with EVs (10 µg
protein) for 24 h. Subsequently, the cells were plated at a density of 250 cells per well in 96-well ultra-
low attachment plates (Corning, NY, USA) in serum-free DMEM/F12 medium supplemented with 1´B27
(Invitrogen, 17504001), 20 ng/ml EGF (R&D Systems, USA), 10 ng/ml bFGF (R&D Systems, USA) and
1% methylcellulose (Sigma-Aldrich, USA) and cultured under normoxic or hypoxic conditions. After 7
days in culture, the spheroids containing at least 50 cells were counted under an inverted microscope
(Motic, #AE31E). Clonal origin of SW480 spheroids was verified by co-culturing of DiD (Thermo Fisher
Scientific, #V22887) and DiO (Thermo Fisher Scientific, #V22886) labelled cells at a density of 250 cells
per well. The assay was performed in six replicates at two independent times.
Statistical analysis. All statistical analyses were performed using GraphPad Prism software version 7
(GraphPad Software, Inc, USA). The data are represented in graphs as means ± SD of two independent
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experiments each performed in replicates. Statistical significance was determined by the nonparametric
Mann-Whitney U test and the differences were considered significant at p<0.05.
Results
Characteristics of normoxic and hypoxic EVs. EVs were isolated by a combination of centrifugation,
filtration and SEC from the conditioned medium of human isogenic CRC cell lines SW480 and SW620,
which had been cultured as multicellular spheroids under either normoxic or hypoxic conditions. The
hypoxic conditioning of the cells was verified by immunofluorescence (Figure 1A) and western blot
analysis (Figure 1B) both of which showed a strong induction of two hypoxia markers – HIF1a and
CAIX in the hypoxia-exposed, but not in the normoxia grown spheroids. Isolated EVs were characterized
by western blot analysis, transmission electron microscopy (TEM) and NTA. Western blot analysis
showed that SW480 and SW620-derived EVs were positive for classic EV markers ALIX and TSG101
(Figure 1B). Compared to the cells, EVs were enriched in CD9, but negative for the endoplasmic
reticulum protein calnexin, thus showing that the EV preparations did not contain detectable amounts of
intracellular components. Interestingly, hypoxic EVs were strongly enriched in carbonic anhydrase IX
(CAIX) – a hypoxia-inducible enzyme with an extracellular catalytic domain that is overexpressed in
various cancers and plays a crucial role in the regulation of intracellular and extracellular pH (21). TEM
images showed that the majority of vesicles were 40 to 200 nm in diameter (Figure 1C). NTA revealed a
significant increase in the number of EVs released under hypoxic conditions by SW480 and SW620 cells
(2.12-fold, p=0.05 and 1.3-fold, p=0.05, respectively) (Figure 1D), while the size distributions were not
significantly different between the conditions. To test whether the increased production of EVs depended
on HIF signaling, cells were grown in the presence of chetomin, an inhibitor of HIF-1 that disrupts the
binding of HIF-1a and HIF-2a to the coactivator p300 (22). NTA showed that the treatment with
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chetomin abrogated the hypoxia-induced increase in the EV production in both cell lines, thus linking the
HIF signaling with the increased release of EVs (Figure 1D).
EV interactions with hypoxia-naïve CRC cells. To investigate the interaction/uptake of normoxic and
hypoxic EVs by hypoxia-naïve cancer cells, SW480 and SW620 cells were incubated with PKH67-
labelled EVs for 24 h and analyzed by flow cytometry. The results showed that hypoxic EVs interacted
with SW480 and SW620 cells more efficiently than normoxic EVs (Figure 2A). The uptake assay was
also performed at hypoxic conditions, however no significant differences between the conditions were
observed. This suggested that the EV surface molecule composition was altered under hypoxic conditions
in a way that facilitated their interaction and/or uptake by cancer cells. Furthermore, the
interaction/uptake of EVs (independently of hypoxia status) by SW480 was substantially higher than that
by SW620 cells, thus suggesting that cancer-derived EVs interact with primary tumor cells more
efficiently than with metastatic cells.
To further investigate the mode of interaction of EVs with hypoxia-naïve SW480 cells, PKH67-lebelled
hypoxic SW480-derived EVs were incubated with SW480 cells for 24 h and analyzed by confocal
microscopy. PKH67-lebelled EVs were internalized and located in the cytoplasm of SW480 cells. To rule
out the transfer of unincorporated PKH67 dye, cells were incubated with a negative control - PKH67 dye
that was subjected to the EV labelling protocol (Figure 2B).
Effects of EVs on proliferation and spheroid forming ability of CRC cells. To assess the effects of EVs on
the growth properties of CRC cells, proliferation and spheroid-forming assays were performed. The
proliferation assay showed that the EVs did not have any significant effect on the number of viable cells
(data not shown). For the spheroid-forming assay, SW480 and SW620 cells were pre-incubated with
normoxic and hypoxic EVs for 24 h and then plated at low density in methylcellulose-containing serum-
free defined medium. Under these conditions, cells formed floating 3D multicellular spheroids originating
from a single cell not by aggregation of cells (Figure 3A). This assay showed that the pre-incubation of
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SW480 cells with hypoxic EVs from either SW480 or SW620 cells significantly increased the number of
spheroid-forming cells as compared to normoxic EVs or PBS control (Figure 3B upper panel). In contrast,
hypoxic SW480-derived EVs only marginally increased the spheroid forming ability of SW620 cells,
whereas SW620-derived EVs did not have an impact on the spheroid forming ability of SW620 cells
(Figure 3B lower panel). However, SW620 cells per se had a higher spheroid-forming ability than SW480
cells.
Effects of EVs on motility and invasiveness of CRC cells. To interrogate the effects of normoxic and
hypoxic EVs on the motility and invasiveness of hypoxia-naïve SW480 and SW620 cells, scratch wound
healing and BME invasion assays were performed. The scratch wound healing assay showed that SW480
cells filled the scratch significantly faster in the presence of hypoxic SW480 and SW620 EVs as
compared to normoxic EVs or PBS control (Figure 4A, B left panel). As the proliferation assay did not
reveal any effect of the EVs on the growth rate, this effect was likely due to increased motility, not
proliferation of cells. At the same time, these EVs did not have a significant effect on the motility of
SW620 cells (Figure 4B, right panel). In line with these findings, the BME cell invasion assay showed
that hypoxic SW480 and SW620-derived EVs significantly increased the invasion of SW480 cells
through the BME- coated membranes, while again they did not have any significant effect on the
invasiveness of SW620 cells (Figure 4C).
Discussion
Hypoxic microenvironment is an important driving force of tumor progression. Increasing evidence
shows that hypoxia-induced signaling promotes cancer cell invasion, metastasis, angiogenesis, self-
renewal capacity, chemoresistance and metabolic reprogramming (2, 5). However, while the intracellular
signaling events have been studied for several decades, our understanding about the intercellular signaling
under hypoxic conditions has just started to shape up and EVs appear to serve as one of the main tools for
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communication among cancer cells and between cancer and host cells. EVs secreted by hypoxic cancer
cells have previously been shown to promote the invasiveness, migration and spheroid-forming ability of
hypoxia-naïve cancer cells in prostate cancer and oral squamous cell carcinoma (23, 24), and to confer
more aggressive and chemoresistant phenotype to ovarian cancer cells (25). Moreover, hypoxic tumor-
derived EVs have been shown to promote angiogenesis (16, 26) and induce M2 macrophage polarization
(27).
Here, hypoxia stimulated the release of EVs from CRC cells and this effect was mediated by HIF1. Given
that hypoxia has been shown to enhance the release of EVs by breast (28) and ovarian (25) cancer cells as
well as by cardiomyocytes (29) and mesenchymal stem cells (MSC) (30), the release of EVs appears to be
a common hypoxia response, but its biological role is likely to be different in various situations. For
example, in case of myocardial ischemia, MSC and cardiac progenitor cell-derived EVs have been shown
to have cardioprotective and regenerative effects (30, 31), and therefore, may have a therapeutic potential
(32), whereas hypoxic cancer-derived EVs appear to have mainly tumor-promoting effects.
Our data showed that hypoxic EVs are taken up by hypoxia-naïve CRC cells more efficiently than
normoxic EVs. This suggests that hypoxic conditions alter the composition of EV surface molecules in a
way that facilitates their uptake. Indeed, our recent proteomic analysis of the surface proteins of EVs
released by hypoxic and normoxic SW480 and SW620 cells revealed 16 hypoxia-induced proteins
including integrin ITGA6, LAMP1, COPB1, ADAM10 etc. (submitted for publication by Nakurte et al.).
However, whether the enhanced uptake is selective only for cancer cells remains to be investigated.
Hypoxic SW480 and SW620 cell-derived EVs stimulated the motility and invasiveness of hypoxia-naïve
primary tumor-derived SW480 cells, whereas they had a little effect on the metastasis-derived SW620
cells. Similarly, they increased the spheroid-forming capacity of SW480, but not SW620 cells. Formation
of clonal multicellular spheroids is associated with increased expression of cancer stem cell markers,
chemoresistance and tumorigenicity and therefore spheroid-forming assay has been widely used as a
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marker for cancer stemness (33-35). Our data showed that primary tumor-derived CRC cells had a greater
capacity to internalize and respond to hypoxic EVs than metastasis-derived cells, thus suggesting that the
biological function of hypoxic cancer-derived EVs could be to propagate an aggressive and invasive
phenotype. However, at this point, it is not clear to what extent these findings can be generalized,
therefore more isogenic cell line pairs should be tested to elucidate if this is a common feature of cancers
in general.
Furthermore, it is not clear whether these effects were caused by internalization of EVs and transfer of
signaling molecules into the recipient cells or via binding of EVs to the cell surface receptors. In prostate
cancer, a number of proteins that are present at higher levels in hypoxic than normoxic EVs including
proteins associated with the epithelial adherens junction and cytoskeleton signaling have been identified
(24). In glioma, hypoxic EVs were found to be enriched with hypoxia-regulated mRNAs and proteins
such as MMPs, IL-8, caveolin 1 (26), as well protein-lysine 6-oxidase, thrombospondin-1 and VEGF
(36). However, direct proof that these proteins are the cause of functional changes in the recipient cells is
yet lacking. Hypoxic EVs are also known to deliver miRNAs to recipient cells (7). In fact, hypoxic oral
squamous cell carcinoma-derived EVs have been shown to contain high levels of miR-21 and its
depletion in the cells resulted in reduced migration and invasion of the recipient hypoxic oral squamous
carcinoma cells, suggesting that these effects indeed might be mediated by transfer of miR-21 (23).
Alternatively, it is possible that the intracellular signaling is triggered by binding of EVs to the cell
surface receptors, not by internalization of EVs, as it has recently been shown in T cells (37, 38).
In summary, hypoxia enhanced the release of EVs from CRC cells in a HIF1-dependent manner. Hypoxic
EVs were taken up by hypoxia-naïve CRC cells more efficiently than normoxic EVs and they enhance
motility, invasiveness and stemness of primary tumor-derived SW480 cells. Our data support the
hypothesis that hypoxia promotes the progression of CRC via paracrine EV-mediated signaling conferring
aggressiveness and invasiveness to hypoxia-naïve cancer cells in the primary tumor, whereas metastatic
cells are less responsive to these signals.
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Figure 1. Characterisation of normoxic and hypoxic SW480 and SW620-derived EVs. A) Verification of
hypoxic cell culture conditions by immunofluorescence using anti-HIF1a and CAIX antibodies. N:
Normoxia; H: hypoxia. Scale bars are 37.5 mm. B) Western blot analysis of hypoxia (HIF1a and CAIX)
and EV markers (ALIX, TSG101, CD9) in SW480 and SW620 cells and EVs. Calnexin was used as a
control for EV purity and b-actin as a loading control. C) Transmission electron microscopy image of
normoxic SW480 and SW620-derived EVs showing the size range and morphology of vesicles. Scale bar
is 200 nm. D) Nanoparticle tracking analysis of EVs released by normoxic and hypoxic SW480 and
SW620 cells in the presence or absence of chetomin. *p<0.05.
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Figure 2. Uptake of normoxic and hypoxic EVs by hypoxia-naïve CRC cells. A) Percentage of PKH67-
positive SW480 and SW620 cells after incubation with PKH67-labelled EVs for 24 h determined by flow
cytometry analysis. B) EV uptake by SW480 cells visualized by confocal microscopy. Left panel - PKH67-
labelled EVs; right – negative control. Scale bar is 10 mm. *p<0.05.
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Figure 3. Effects of EVs on spheroid-forming ability of CRC cells. A) The clonal origin of 3D
multicellular spheroids was verified by co-culturing of DiD and DiO-labelled SW480 cells. Mostly single-
labelled spheroids were observed, when the cells were plated in methylcellulose-containing serum-free
medium at a density of 250 cells/well. Scale bar is 37.5 mm. B) The number of multicellular spheroids
formed by 250 SW480 and SW620 cells after 7 days of culturing in methylcellulose-containing serum-free
defined medium. *p<0.05.
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Figure 4. Effects of normoxic and hypoxic EVs on the motility and invasiveness of CRC cells. A)
Representative images of scratch wound healing assay of SW480 cells treated with hypoxic and normoxic
SW620-derived EVs. B) Graphs showing gap closure after 24 h. C) BME Cell Invasion assay showing the
number of cells that migrated through BME coated membranes to the bottom chamber quantified using
Calcein AM. *p<0.05.
